Spiramycin Disarms Pseudomonas aeruginosa without Inhibiting Growth

Spiramycin is a 16-membered macrolide antibiotic currently used in therapy to treat infections caused by Gram-positive bacteria responsible for respiratory tract infections, and it is also effective against some Gram-negative bacteria and against Toxoplasma spp. In contrast, Pseudomonas aeruginosa,...

Descripción completa

Detalles Bibliográficos
Autores principales: Calcagnile, Matteo, Jeguirim, Inès, Tredici, Salvatore Maurizio, Damiano, Fabrizio, Alifano, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044227/
https://www.ncbi.nlm.nih.gov/pubmed/36978366
http://dx.doi.org/10.3390/antibiotics12030499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044227/
https://www.ncbi.nlm.nih.gov/pubmed/36978366
http://dx.doi.org/10.3390/antibiotics12030499

Ejemplares similares